Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Abbott receives CE Mark for the TactiFlex Duo Ablation Catheter to treat patients with abnormal heart rhythms

Written by | 26 Jan 2026

Abbott announced it has received CE Mark in Europe for the TactiFlex Duo Ablation Catheter, Sensor Enabled to treat patients with atrial fibrillation (AFib). Following the new approval,… read more.

Six weeks in a cast no less effective than surgery for unstable ankle fractures

Written by | 25 Jan 2026

Wearing a cast for six weeks appears to be no less effective than surgery for healing unstable ankle fractures and carries fewer treatment related harms, finds a clinical trial from… read more.

Substantial ongoing under-diagnosis of high blood pressure in the over 50s in Ireland

Written by | 25 Jan 2026

High blood pressure becomes more common after age 40years yet new research from The Irish Longitudinal Study on Ageing (TILDA) at Trinity College Dublin shows that many people… read more.

Sobi receives European Commission approval for Aspaveli (pegcetacoplan) for the treatment of C3G and primary IC-MPGN

Written by | 25 Jan 2026

Sobi announced that the European Commission (EC) has approved Aspaveli (pegcetacoplan) for the treatment of adult and adolescent patients aged 12 to 17 years with C3 glomerulopathy (C3G)… read more.

Long-term data support option of antibiotics for appendicitis

Written by | 24 Jan 2026

Initial treatment with antibiotics is a viable option for uncomplicated acute appendicitis in adult patients, researchers reported in JAMA on January 21, 2026. “What is the long-term appendicitis… read more.

The stop-smoking medication varenicline may also work for cannabis use disorder

Written by | 24 Jan 2026

A new randomised controlled trial has found promising evidence that the smoking cessation medication varenicline (Chantix/Champix) can help people with cannabis use disorder (CUD) to reduce cannabis use. … read more.

Camurus announces FDA acceptance of NDA resubmission for Oclaiz (octreotide) for the treatment of acromegaly

Written by | 24 Jan 2026

Camurus announced that the FDA has accepted for review the company’s resubmission of the New Drug Application (NDA) for Oclaiz (CAM 2029), octreotide extended-release injection, for the treatment… read more.

1 in 5 surveyed UK adults who have experienced the death of a pet report it as more distressing than experienced human deaths, with significant rates of prolonged grief disorder symptoms also being reported following pet loss

Written by | 23 Jan 2026

Article URL: https://plos.io/3LmqYmf Background Prolonged grief disorder (PGD) is a psychiatric disorder in ICD-11 and DSM-5-TR that can only be diagnosed following the death of a person. Despite considerable… read more.

Why a life-threatening sedative is being prescribed more often for seniors

Written by | 23 Jan 2026

When agitated dementia patients wander or shout through the night, families and caregivers understandably feel the need to treat this frightening and potentially dangerous behavior.  Antipsychotic medications are… read more.

Eylea (aflibercept) 8 mg approved in the EU for third retinal indication – Bayer

Written by | 23 Jan 2026

The European Commission has granted marketing authorization in the European Union (EU) for Eylea 8 mg (aflibercept 8 mg, 114.3 mg/ml solution for injection) for the treatment of… read more.

Mpox infection is often followed by lingering physical symptoms

Written by | 22 Jan 2026

A study of adults diagnosed with mpox between May 2022 and January 2023 reveals that over half of the subjects diagnosed with mpox during the 2022 outbreak had… read more.

Paracetamol use in pregnancy does not appear to increase risk of autism, ADHD or intellectual disabilities

Written by | 22 Jan 2026

Researchers report that paracetamol use during pregnancy does not raise the risk of autism, attention-deficit/hyperactivity disorder (ADHD), or intellectual disability among exposed children. The findings were published on… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.